2015
DOI: 10.1016/j.cyto.2014.11.009
|View full text |Cite
|
Sign up to set email alerts
|

Relationship of common vascular endothelial growth factor polymorphisms and haplotypes with the risk of cervical cancer in Tunisians

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 35 publications
0
15
0
1
Order By: Relevance
“…While not tested for its possible association with PCOS, rs3025020 (-583T>C) was previously linked with increased risk of recurrent pregnancy loss in Bahraini [24] and Chinese [25] women. While some of the SNPs included here were previously investigated in relation to other adverse pregnancy complications, including ovarian hyper-stimulation syndrome [35], recurrent miscarriage [24, 25], preeclampsia [22, 23], ovarian cancer [21], and cervical cancer [26] with variable results. As such, our finding on its association with PCOS expands the contribution of rs3025020 to adverse pregnancy complications.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…While not tested for its possible association with PCOS, rs3025020 (-583T>C) was previously linked with increased risk of recurrent pregnancy loss in Bahraini [24] and Chinese [25] women. While some of the SNPs included here were previously investigated in relation to other adverse pregnancy complications, including ovarian hyper-stimulation syndrome [35], recurrent miscarriage [24, 25], preeclampsia [22, 23], ovarian cancer [21], and cervical cancer [26] with variable results. As such, our finding on its association with PCOS expands the contribution of rs3025020 to adverse pregnancy complications.…”
Section: Discussionmentioning
confidence: 99%
“…Two studies conducted on Turkish [19] and South Indian [20] cohort revealed no association between -2578C/A and -460T/C VEGFA SNPs and PCOS. Other studies that investigated the association between VEGFA SNPs and adverse pregnancy outcomes, such as ovarian hyperstimulation syndrome, ovarian cancer [21], pre-eclampsia [22, 23], spontaneous miscarriage [24, 25], and cervical cancer [26] yielded mixed results. This study evaluated the association of VEGFA variants with altered VEGF level and PCOS in 382 Bahraini Arab women with PCOS, and 393 age- and ethnically-matched control women.…”
Section: Introductionmentioning
confidence: 99%
“…A case-control study in a Chinese population suggested that VEGF -2578C/A polymorphism plays an important role in the pathogenesis of osteosarcoma (Tie et al, 2014). Another case-control study investigated the association between common SNPs in VEGF and risk of cervical cancer in a Tunisian population, and it suggested that VEGF -2578C/A polymorphism may contribute to the development of cervical cancer (Zidi et al, 2014). In a case-control study in a Portuguese population, findings suggested that VEGF -2578C/A polymorphism was associated with an increased risk of hepatocellular carcinoma (Machado et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies reported the association between polymorphisms in VEGF -2578C/A and risk of cancer (Tie et al, 2014;Zidi et al, 2014;Machado et al, 2014;Deng et al, 2014;Chen et al, 2014). A case-control study in a Chinese population suggested that VEGF -2578C/A polymorphism plays an important role in the pathogenesis of osteosarcoma (Tie et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
“…Almawi and colleagues [61] tested the association between VEGF polymorphisms and cervical cancer, and reported that specific VEGF variants and a defined haplotype (CTGCCAG) contributed to the risk of cervical cancer. Kahyaoglu and colleagues [62] described the role of cytokines in modulating hormones in ovarian function, and demonstrated that granulocyte-colony stimulating factor (G-CSF) was increased in serum as well as follicular fluid from patients with polycystic ovary syndrome.…”
Section: Introductionmentioning
confidence: 98%